This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
<em>Action Item:</em> Continuing to Transform Non-Small Cell Lung Cancer Evidence into Practice Outcomes with <em>Suggested Options for Practice</em>

Action Item: Continuing to Transform Non-Small Cell Lung Cancer Evidence into Practice Outcomes with Suggested Options for Practice



Time to Complete

1 hour


April 11, 2017


April 11, 2018
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

This activity is provided by Global Education Group.

Commercial Supporter

This activity is supported by an educational grant from Genentech.

Program Description

Action Item: Continuing to Transform Non-Small Cell Lung Cancer Evidence into Practice Outcomes with Suggested Options for Practice is an educational activity that provides clinicians with key summarized issues pertaining to non-small cell lung cancer (NSCLC) immunotherapies and targeted therapies. All information is prepared in brief but concise and clinically accurate portions that are sensitive to the time constraints of busy clinicians. Additionally, each key issue is accompanied by suggested summary options that clinicians may digest and apply to real-life practice for NSCLC care plan management. It is important to note that only evidence-based information that may provide either altered options or pure validation treatment recommendations are highlighted.

Program Agenda

Pre-Test – 5 minutes
Abstracts – 45 minutes
Post-Test – 5 minutes
Evaluation – 5 minutes

Intended Audience

The educational design of this activity addresses the needs of US-based community oncologists and other healthcare professionals involved in the treatment of patients with NSCLC.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Discuss the advances made in NSCLC research that could impact targeted treatment decisions made by the inter-professional oncology team
  • Evaluate the clinical utility of lung cancer immunotherapy in a way that is suitable for the community oncology patient
  • Determine the use of biomarkers that may help select those patients most likely to benefit from current and emerging NSCLC targeted treatments and cancer immunotherapies

Fee and Refund / Cancellation Policy

There is no fee for this educational activity.

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Chirag Bhagat, PharmD, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Laura Gilsdorf has nothing to disclose.
Ashley Marostica, RN, MSN, has nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1
TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a post-test score of 70% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.

If you have any questions relating to the accreditation of this activity, please contact Global Education Group at 303-395-1782 or

If you have any questions relating to other issues with this activity, please contact

Privacy Policy

myCME privacy policy

Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue